Knowledge Content
#### 1. Origin: Syntex's Unmarketed Development
In 1956, the renowned pharmaceutical company Syntex (the same company that developed Anadrol and Primobolan) first synthesized methyldrostanolone (the active ingredient in Superdrol). The original intention was to develop an anti-tumor drug, but the drug was not clinically approved due to its suboptimal efficacy. This aborted development laid the groundwork for subsequent market chaos.
#### 2. Explosive Popularity: The Shady Operations of Dietary Supplement Manufacturers
In late 2004, Designer Supplements LLC in the United States pioneered the packaging of Superdrol as an "anabolic supplement" and sold it online. The first batch of 2,200 bottles sold out in 15 minutes. Production was subsequently transferred to Anabolic Resources through a licensing agreement, circumventing regulations by labeling it a "non-controlled substance." At its peak, annual sales exceeded tens of millions of dollars. However, in 2006, the FDA determined that it contained unapproved steroids and forced its removal from the market. Anabolic Resources was fined $500,000 for fraud.
#### 3. Current Status: Counterfeit Drug Companies Dominate
Currently, most Superdrol 50 (50mg) on the market comes from unlicensed, underground pharmaceutical companies such as Odin Pharmaceuticals, ZPHC, and Genitec Pharm, distributed as oral tablets or injections. These products have not passed regulatory approvals, exhibit significant variations in ingredient purity and dosage, and pose a significantly higher risk of hepatotoxicity than earlier versions.
From the laboratories of regular pharmaceutical companies to the gray market where drugs are circulated underground, the transformation of Superdrol 50's manufacturers is essentially a "history of confrontation between efficacy and regulation." Its current chaotic supply situation also confirms the difficulty in governing the illegal circulation of synthetic steroids.
